• Financial Calendar 2018

    Source: Nasdaq GlobeNewswire / 11 Dec 2017 07:08:00   America/New_York

     

    February 8, 2018   Quiet period prior to the annual report begins (4 weeks)
    March 2, 2018   Deadline for shareholder proposals for the AGM
    March 8, 2018   Annual report for 2017
    April 13, 2018       Annual General Meeting
    April 19, 2018   Quiet period prior to the Interim report begins (2 weeks)
    May 3, 2018   Interim report - 3 months 2018
    August 2, 2018   Quiet period prior to the Interim report begins (2 weeks)
    August 16, 2018   Interim report - 6 months 2018
    October 25, 2018   Quiet period prior to the Interim report begins (2 weeks)
    November 8, 2018   Interim report - 9 months 2018

     

    For further information, please contact:

    Gry Husby Larsen, General Counsel

    Peter M. Eriksen, CEO

    Telephone +45 4529 0000, e-mail investor@bioporto.com

    About BioPorto

    BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Our pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.

     

     

Share on,